Navigation Links
Dronedarone (Multaq(R)) Reduced the Incidence and Duration of Hospitalization in Patients with Atrial Fibrillation
Date:11/11/2008

New post-hoc analysis from ATHENA Study showed that Multaq(R) on top of standard therapy significantly decreased the total number of hospital days by 28% in patients with atrial fibrillation or flutter

NEW ORLEANS, Nov. 11 /PRNewswire-FirstCall/ -- New data from the landmark ATHENA trial showed that dronedarone significantly reduced the incidence and total duration of hospital stays among patients with atrial fibrillation/atrial flutter (AF/AFL). This post-hoc analysis was presented at the 2008 American Heart Association Scientific Sessions in New Orleans, Louisiana.

In this new analysis, dronedarone significantly reduced the total number of hospital days by 28 percent (p<0.001) versus placebo (9,995 days vs. 13,986 days), and decreased by 35 percent (p<0.001) the total length of time spent in hospital for cardiovascular reasons (5,875 days vs. 9,073 days).

In addition to the demonstrated reduction of AF-related hospitalization by 37 percent (p<0.001), dronedarone reduced the incidence of first non-AF related CV hospitalization (e.g. myocardial infarction or unstable angina by 14 percent (p=0.016). Dronedarone did not increase the incidence of non-cardiovascular hospitalizations in comparison to the placebo arm.

"The incidence of AF-related hospital admissions has dramatically increased in recent years, and therapeutic solutions to reduce this burden are needed," said Dr. Christian Torp-Pedersen from the Gentofte University Hospital, Copenhagen, Denmark and a member of the steering committee of the ATHENA study. "These new ATHENA data showed that, for the first time, an anti-arrhythmic drug significantly and consistently reduced hospitalization incidence and duration, which led to a substantial reduction of total hospitalization burden in this patient population."

A second post-hoc analysis from ATHENA also presented during the AHA, confirmed the rhythm and rate controlling properties of dronedarone, previously demonstrated
'/>"/>

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
2. ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress
3. ATHENA Clinical Results with Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress
4. Multaq(R) (dronedarone) Granted FDA Priority Review for Patients with Atrial Fibrillation
5. American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate Control in Patients With Permanent Atrial Fibrillation
6. Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation
7. Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation
8. New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
9. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
10. Risedronate Reduced Risk of Fracture Among Osteoporotic Postmenopausal Women with History of Hip Fracture
11. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... Dec. 6 The FDA has approved ... breast cancer sooner and faster. The SonoCine Automated ... only one facility in Arizona - Arizona Breastnet, ... as a breast cancer screening tool to enhance ... been used for diagnostic purposes - not for ...
(Date:12/4/2009)... 4 A simple, inexpensive computer tool that measures ... the lungs picked up by a CT scanner can ... enable doctors to diagnose true cancers with fewer, less ... ) ,, The new diagnostic guidelines are described in ...
(Date:12/4/2009)... (VRML) (Pink Sheets: VRMLQ) announced that on December 3, 2009, ... amended Disclosure Statement with the United States Bankruptcy Court for ... consider the adequacy of the Disclosure Statement is presently scheduled ... of the Plan scheduled for January 7, 2010. ,, "We ...
Breaking Medicine Technology:New FDA Approved Breast Cancer Screening Tool 2New FDA Approved Breast Cancer Screening Tool 3European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Biophysical Society Announces 2010 society fellows 9794 1Anthem Life Offers The Healing Book to Help Young Life Insurance Beneficiaries Cope with Losing a Loved One 56275 1Anthem Life Offers The Healing Book to Help Young Life Insurance Beneficiaries Cope with Losing a Loved One 56275 2Fruit Even Healthier Than Thought 3A Study 56271 1
... provider of clinical services and trial management technologies for ... along with its client Genentech, Inc as the winner ... Clinical Trial Portal solution. Winners were selected from ... panel of 14 expert judges. The ePharmaSolutions Clinical ...
... Using a steroid drug for multiple sclerosis (MS) in ... disease activity more than using the MS drug alone, according ... Program at the American Academy of Neurology,s 61st Annual Meeting ... the study, people with MS received the steroid drug methylprednisolone ...
Other Medicine Technology:ePharmaSolutions' Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award 2Adding Steroid Drug to MS Treatment May Reduce Disease Activity 2
(Date:12/5/2009)... places, and to do everything from growing mushrooms, making wine to keeping ... ... have thought that your wine, water and vegetables would have come from ... line of turbines, for industry end users, not wind farms. "Using ...
(Date:12/4/2009)... Care Investment Trust Inc. (NYSE: CRE ) ... has declared a dividend of $0.17 per share of common stock. ... shareholders of record on December 14, 2009. ,, ... is a real estate investment and finance company investing in healthcare-related ...
(Date:12/4/2009)... 4 Medithrive, Inc. has won the Patient,s Choice ... Area by popular vote conducted by the online website, ... the SF Bay community has selected Medithrive as the ... The rapid rise and popularity of Medithrive confirms the ...
(Date:12/4/2009)... of Homes and Services for the Aging (AAHSA) applauds the ... Services (CLASS) provisions remain in the final health reform legislation ... elders, people with disabilities and their caregivers. ,, We ... that will make it affordable to care for families and ...
(Date:12/4/2009)... KANSAS CITY, Mo., Dec. 4 The large, two-day free ... (NAFC) in Kansas City on Wednesday and Thursday is not ... uninsured and has not seen a doctor recently. All participants ... ,, "Many people who attended the three previous large free ...
Breaking Medicine News(10 mins):Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Free Health Clinic Event Is Not Just for the Sick 2
... Exhibit, ... March 25-26, 2008, WASHINGTON, Dec. ... judges has selected the finalists for its,inaugural Best Practices in Consumer ... proven programs that are enhancing patient safety and giving,consumers more control ...
... Rehabilitation Centers of,America, Inc. (Navitas), the market ... services, is pleased to announce that,its Denver, ... campus of Presbyterian/St.,Luke,s Medical Center. Navitas has ... Luke,s to provide its proprietary cancer,rehabilitation program ...
... in unprotected sex, but with those already carrying the virus ... infected with HIV (the virus that causes AIDS) choose to ... researchers who analyzed data from six clinics in San Francisco, ... Providence, R.I. , The study included 27 men with acute ...
... million Americans, Osteoarthritis of the knee (OA) is one ... elderly. While OA mainly affects most people over ... placebo-controlled study published in the journal Nutrition Research reveals ... of the French maritime pine tree, improved physical function ...
... In about 20 percent of women with breast cancer ... imaging reveals important diagnostic information that alters their treatment ... , This study was presented at the 119th annual ... in Hot Springs, Va., and will appear in the ...
... typical in later years, study suggests , , WEDNESDAY, Nov. ... the biological underpinnings of "senior moments," new research shows ... to break down as a person grows older. , ... cognition in normal aging," said lead researcher Randy Buckner, ...
Other Medicine News:Health News:URAC Names Sensei for Weight Loss as a Finalist in First-Ever Best Practices in Consumer Empowerment and Protection Awards 2Health News:URAC Names Sensei for Weight Loss as a Finalist in First-Ever Best Practices in Consumer Empowerment and Protection Awards 3Health News:Navitas Opens Cancer Rehabilitation Center in Denver in Conjunction With Presbyterian / St. Luke's Medical Center 2Health News:Navitas Opens Cancer Rehabilitation Center in Denver in Conjunction With Presbyterian / St. Luke's Medical Center 3Health News:Newly HIV-Infected Gay Men Select Other Infected Partners 2Health News:Study shows pine bark naturally reduces osteoarthritis knee pain 2Health News:Study shows pine bark naturally reduces osteoarthritis knee pain 3Health News:Breast MRI spots other cancers, may alter treatment plan 2Health News:Breast MRI spots other cancers, may alter treatment plan 3Health News:Breast MRI spots other cancers, may alter treatment plan 4Health News:Aging Brains Get Out of Sync 2Health News:Aging Brains Get Out of Sync 3
... IEC-Innovative Endoscopy Components, LLC ... Medical Equipment "Made in ... are manufactured according to ... the most excellent design ...
... sensitive DR system. It features a 17 ... designed for most general radiographic applications. Versatile ... stand and table configurations. , ,With ... detailed patient images with reduced dose. The ...
... to provide the surgeon with an optimal work ... during cataract and retinal surgery. Perfect Pupil Injectable ... sized pupils which allows expansion of the pupil ... surgery, and allows the pupil to return to ...
... remove bone cement speedily and efficiently. , ,The ... at the point of contact, allowing it to ... of the apparatus is its ability to recognize ... the operator instantly. Probe position can thus be ...
Medicine Products: